NO127814B - - Google Patents
Download PDFInfo
- Publication number
- NO127814B NO127814B NO00170961A NO17096167A NO127814B NO 127814 B NO127814 B NO 127814B NO 00170961 A NO00170961 A NO 00170961A NO 17096167 A NO17096167 A NO 17096167A NO 127814 B NO127814 B NO 127814B
- Authority
- NO
- Norway
- Prior art keywords
- resin
- inclusion
- resins
- cross
- compounds
- Prior art date
Links
- 239000011347 resin Substances 0.000 claims description 33
- 229920005989 resin Polymers 0.000 claims description 33
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 9
- 229920000858 Cyclodextrin Polymers 0.000 claims description 7
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 7
- 239000003463 adsorbent Substances 0.000 claims description 4
- 239000003223 protective agent Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000007800 oxidant agent Substances 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 description 13
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 239000003431 cross linking reagent Substances 0.000 description 3
- 150000002484 inorganic compounds Chemical class 0.000 description 3
- ICIWUVCWSCSTAQ-UHFFFAOYSA-M iodate Chemical compound [O-]I(=O)=O ICIWUVCWSCSTAQ-UHFFFAOYSA-M 0.000 description 3
- 150000002894 organic compounds Chemical class 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 229920000856 Amylose Polymers 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 125000002015 acyclic group Chemical group 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- DEWLEGDTCGBNGU-UHFFFAOYSA-N 1,3-dichloropropan-2-ol Chemical compound ClCC(O)CCl DEWLEGDTCGBNGU-UHFFFAOYSA-N 0.000 description 1
- FSBYOEHUNSUUTD-UHFFFAOYSA-N 2-(2,5-dioxabicyclo[2.1.0]pentan-3-yloxy)ethanol Chemical compound C1(C2C(O2)O1)OCCO FSBYOEHUNSUUTD-UHFFFAOYSA-N 0.000 description 1
- LSTZTHCEEPHCNQ-UHFFFAOYSA-N 3-(2,5-dioxabicyclo[2.1.0]pentan-3-yloxy)-2,5-dioxabicyclo[2.1.0]pentane Chemical compound C1(C2C(O2)O1)OC1C2C(O2)O1 LSTZTHCEEPHCNQ-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical class N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 1
- ZFIVKAOQEXOYFY-UHFFFAOYSA-N Diepoxybutane Chemical compound C1OC1C1OC1 ZFIVKAOQEXOYFY-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- -1 lithium aluminum hydride Chemical compound 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000012261 resinous substance Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 description 1
- 229960002218 sodium chlorite Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
- A23L27/72—Encapsulation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
- A23L27/74—Fixation, conservation, or encapsulation of flavouring agents with a synthetic polymer matrix or excipient, e.g. vinylic, acrylic polymers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
- A23L27/75—Fixation, conservation, or encapsulation of flavouring agents the flavouring agents being bound to a host by chemical, electrical or like forces, e.g. use of precursors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
- C07C201/06—Preparation of nitro compounds
- C07C201/16—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/16—Cyclodextrin; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH561564A CH445129A (fr) | 1964-04-29 | 1964-04-29 | Procédé pour la préparation de composés d'inclusion à poids moléculaire élevé |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO127814B true NO127814B (da) | 1973-08-20 |
Family
ID=4296563
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO00157873A NO126377B (da) | 1964-04-29 | 1965-04-28 | |
| NO00170961A NO127814B (da) | 1964-04-29 | 1967-12-13 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO00157873A NO126377B (da) | 1964-04-29 | 1965-04-28 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US3420788A (da) |
| BE (1) | BE662174A (da) |
| CH (1) | CH445129A (da) |
| DK (1) | DK132259C (da) |
| ES (1) | ES312034A1 (da) |
| GB (1) | GB1091637A (da) |
| IT (1) | IT961352B (da) |
| NL (1) | NL6505361A (da) |
| NO (2) | NO126377B (da) |
| SE (2) | SE365234B (da) |
Families Citing this family (112)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU177419B (en) * | 1978-07-13 | 1981-10-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing threedimensional,retentive polymers consisting of cyclodextrin and polyvinylalcohol units,capable of forming inclusion complexes in the form of bead,fibre or mainly block |
| EP0013688B1 (en) * | 1978-12-15 | 1984-02-01 | Kyoshin Co., Ltd. | A perfumed synthetic resin product and a method of producing said product |
| JPS609524B2 (ja) * | 1979-06-01 | 1985-03-11 | 理化学研究所 | シクロデキストリンの回収法 |
| HU184066B (en) * | 1979-12-28 | 1984-06-28 | Chinoin Gyogyszer Es Vegyeszet | Plant growth regulating substance and process for preparing such compound |
| HU181733B (en) * | 1980-08-07 | 1983-11-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing sorbents containing cyclodextrin on cellulose base |
| JPS57130914A (en) * | 1981-02-04 | 1982-08-13 | Agency Of Ind Science & Technol | Prolongation of activity retention |
| HU189534B (en) * | 1981-09-09 | 1986-07-28 | Chinoin Rt.,Hu | Process for producing new tablets containing cyclodextrin polymer as desintegrator |
| US4448789A (en) * | 1982-08-27 | 1984-05-15 | Warner-Lambert Company | Enhanced flavor-releasing agent |
| HU191101B (en) * | 1983-02-14 | 1987-01-28 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu | Process for preparing water-soluble cyclodextrin polymers substituted with ionic groups |
| JPS6081166A (ja) * | 1983-10-11 | 1985-05-09 | Fujisawa Pharmaceut Co Ltd | ２−ニトロオキシメチル−６−クロロピリジンのβ−シクロデキストリン包接化合物およびその製造法 |
| JPS60202115A (ja) * | 1984-03-27 | 1985-10-12 | Ichiro Shibauchi | エポキシ樹脂用硬化剤 |
| US4727064A (en) * | 1984-04-25 | 1988-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Pharmaceutical preparations containing cyclodextrin derivatives |
| US4596795A (en) * | 1984-04-25 | 1986-06-24 | The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services | Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives |
| JPS61152765A (ja) * | 1984-12-27 | 1986-07-11 | Nippon Ekishiyou Kk | シクロデキストリン類で包接された化合物を含有した合成樹脂製品及びその製造方法 |
| US4769474A (en) * | 1985-04-10 | 1988-09-06 | Mitsui Toatsu Chemicals, Inc. | Process for purifying tryptophane |
| SE452469B (sv) * | 1986-06-18 | 1987-11-30 | Pharmacia Ab | Material bestaende av en tverbunden karboxylgrupphaltig polysackarid och forfarande vid framstellning av detsamma |
| US4897472A (en) * | 1986-11-19 | 1990-01-30 | Oy Alko Ab | Process for isolation and purification of cyclodextrins |
| US5273820A (en) * | 1986-12-08 | 1993-12-28 | American Maize-Products Company | Separation and purification of cyclodextrins |
| US4808232A (en) * | 1986-12-08 | 1989-02-28 | American Maize-Products Company | Separation and purification of cyclodextrins |
| US4898921A (en) * | 1987-06-03 | 1990-02-06 | Montclair State College | Conducting polymer films, method of manufacture and applications therefor |
| US5658894A (en) * | 1989-04-23 | 1997-08-19 | The Trustees Of The University Of Pennsylvania | Compositions for inhibiting restenosis |
| US5760015A (en) * | 1988-01-19 | 1998-06-02 | The Trustees Of The University Of Pennsylvania | Cyclodextrin compounds and methods of making and use thereof |
| US5637575A (en) * | 1988-01-19 | 1997-06-10 | The Trustees Of The University Of Pennsylvania | Methods of inhibiting restenosis |
| JPH0269540A (ja) * | 1988-09-05 | 1990-03-08 | Chisso Corp | 結晶性ポリオレフイン組成物 |
| US5441944A (en) * | 1989-04-23 | 1995-08-15 | The Trustees Of The University Of Pennsylvania | Substituted cyclodextrin sulfates and their uses as growth modulating agents |
| US5075432A (en) * | 1989-08-11 | 1991-12-24 | Edward Vanzo | Spherical cyclodextrin polymer beads |
| IT1255981B (it) * | 1991-04-30 | 1995-11-17 | Ministero Dell Uni E Della | Composizione adesiva a piu' componenti |
| US5446030A (en) * | 1991-09-19 | 1995-08-29 | Weisz; Paul B. | Prevention of hemolysis |
| EP0697874A1 (en) * | 1993-03-31 | 1996-02-28 | The Trustees Of The University Of Pennsylvania | Methods of affecting the growth of living tissue in mammals and compounds and compositions therefor |
| US5492947A (en) * | 1994-06-23 | 1996-02-20 | Aspen Research Corporation | Barrier material comprising a thermoplastic and a compatible cyclodextrin derivative |
| US6048736A (en) * | 1998-04-29 | 2000-04-11 | Kosak; Kenneth M. | Cyclodextrin polymers for carrying and releasing drugs |
| JP2006515640A (ja) * | 2003-01-16 | 2006-06-01 | コーネル・リサーチ・ファンデーション・インコーポレイテッド | 部分的に生分解可能な温度およびｐＨ感受性ヒドロゲル |
| US7786290B2 (en) | 2003-06-13 | 2010-08-31 | Alnylam Pharmaceuticals, Inc. | Double-stranded ribonucleic acid with increased effectiveness in an organism |
| ES2515092T3 (es) | 2003-12-11 | 2014-10-29 | Sunovion Pharmaceuticals Inc. | Combinación de un sedante y un modulador neurotransmisor y métodos de mejorar la calidad del sueño y de tratar la depresión |
| US7632485B2 (en) | 2004-02-24 | 2009-12-15 | Massachusetts General Hospital | Catalytic radiofluorination |
| JP4584987B2 (ja) | 2004-04-30 | 2010-11-24 | アルニラム ファーマスーティカルズ インコーポレイテッド | Ｃ５修飾ピリミジンを含むオリゴヌクレオチド |
| US7851637B2 (en) | 2004-06-17 | 2010-12-14 | Infinity Pharmaceuticals, Inc. | Compounds and methods for inhibiting the interaction of BCL proteins with binding partners |
| CA2598271A1 (en) * | 2005-02-18 | 2006-08-24 | Surface Logix, Inc. | Pharmacokinetically improved compounds |
| JP2008530246A (ja) * | 2005-02-18 | 2008-08-07 | サーフェイス ロジックス，インコーポレイティド | 機能性残基又は官能基を含む薬物動態学的に改善された化合物、及び上述の化合物を含む医薬組成物の製造方法 |
| ES2310948B2 (es) | 2005-02-25 | 2009-09-16 | Universidade De Santiago De Compostela | Procedimiento de obtencion de hidrogeles de ciclodextrinas con glicidileteres, las composiciones obtenidas y sus aplicaciones. |
| WO2006124726A2 (en) * | 2005-05-12 | 2006-11-23 | The General Hospital Corporation | Novel biotinylated compositions |
| KR100791978B1 (ko) * | 2005-06-21 | 2008-01-04 | 곽해수 | 콜레스테롤 제거용 베타-싸이클로덱스트린의 가교화 및그의 재생방법 |
| BRPI0714793A2 (pt) | 2006-08-03 | 2015-06-16 | Tufts College | Análogos de niacina não enrubecedores e método de uso dos mesmos. |
| KR100785913B1 (ko) * | 2006-11-29 | 2007-12-17 | 한국과학기술연구원 | 경화된 β-사이클로덱스트린 중합체 분말과 그의 제조방법 |
| WO2009013770A1 (en) * | 2007-07-26 | 2009-01-29 | Humanitas Mirasole S.P.A. | Derivatised polysaccharide material for the transdermal administration of drugs |
| US20090060860A1 (en) * | 2007-08-31 | 2009-03-05 | Eva Almenar | Beta-cyclodextrins as nucleating agents for poly(lactic acid) |
| EP3404100A1 (en) | 2008-10-24 | 2018-11-21 | Sarepta Therapeutics, Inc. | Multiple exon skipping compositions for dmd |
| CA2779830C (en) | 2009-11-13 | 2020-07-21 | Avi Biopharma, Inc. | Antisense antiviral compound and method for treating influenza viral infection |
| US9068185B2 (en) | 2010-03-12 | 2015-06-30 | Sarepta Therapeutics, Inc. | Antisense modulation of nuclear hormone receptors |
| EP3023496B1 (en) | 2010-05-13 | 2020-07-29 | Sarepta Therapeutics, Inc. | Compounds which modulate interleukins 17 and 23 signaling activity |
| WO2011163612A1 (en) | 2010-06-24 | 2011-12-29 | Trustees Of Tufts College | Niacin mimetics, and methods of use thereof |
| CN103096895B (zh) | 2010-06-24 | 2016-06-01 | 塔夫茨大学信托人 | 烟酸模拟物及其使用的方法 |
| WO2012100142A2 (en) | 2011-01-20 | 2012-07-26 | Cornell University | Treatments for retinal disorders |
| CA2839593A1 (en) | 2011-07-15 | 2013-01-24 | Sarepta Therapeutics, Inc. | Methods and compositions for manipulating translation of protein isoforms from alternative initiation start sites |
| DK2788487T3 (da) | 2011-12-08 | 2018-07-23 | Sarepta Therapeutics Inc | Oligonukleotidanaloger målrettet mod human lmna |
| WO2013096060A1 (en) | 2011-12-23 | 2013-06-27 | Novartis Ag | Compounds for inhibiting the interaction of bcl2 with binding partners |
| MX2014007725A (es) | 2011-12-23 | 2015-01-12 | Novartis Ag | Compuestos para inhibir la interaccion de bcl2 con los componentes de enlace. |
| AU2012355623A1 (en) | 2011-12-23 | 2014-07-17 | Novartis Ag | Compounds for inhibiting the interaction of BCL2 with binding partners |
| US9126980B2 (en) | 2011-12-23 | 2015-09-08 | Novartis Ag | Compounds for inhibiting the interaction of BCL2 with binding partners |
| MX2014007732A (es) | 2011-12-23 | 2015-01-12 | Novartis Ag | Compuestos para inhibir la interaccion de bcl2 con los mismos componentes de enlace. |
| ES2646777T3 (es) | 2012-05-15 | 2017-12-15 | Novartis Ag | Derivados de pirimidina, piridina y pirazina amida sustituidos con tiazol o imidazol y compuestos relacionados como inhibidores de ABL1, ABL2 y BCR-ABL1 para el tratamiento del cáncer, infecciones víricas específicas y trastornos específicos del CNS |
| EP2858988B1 (en) | 2012-05-15 | 2018-02-28 | Novartis AG | Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1 |
| AP3613A (en) | 2012-05-15 | 2016-02-29 | Novartis Ag | Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1 abl1abl2 bcr-abl1 |
| ES2665539T3 (es) | 2012-05-15 | 2018-04-26 | Novartis Ag | Derivados de benzamida para inhibir la actividad de ABL1, ABL2 y BCR-ABL1 |
| WO2014036427A1 (en) | 2012-08-31 | 2014-03-06 | The General Hospital Corporation | Biotin complexes for treatment and diagnosis of alzheimer's disease |
| CN106414739A (zh) | 2012-12-20 | 2017-02-15 | 萨雷普塔医疗公司 | 用于治疗肌营养不良症的改良的外显子跳跃组合物 |
| FR2999916B1 (fr) | 2012-12-20 | 2015-01-30 | Oreal | Composition permettant la liberation d'agent benefique comprenant un polycondensat de cyclodextrine insoluble dans l'eau et au moins un agent benefique |
| FR3000080B1 (fr) | 2012-12-20 | 2015-01-30 | Oreal | Polycondensat de cyclodextrine insoluble dans l'eau ; utilisations comme agent de capture |
| GEP201706638B (en) | 2013-02-19 | 2017-03-10 | Novartis Ag | Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders |
| JP6449231B2 (ja) | 2013-03-14 | 2019-01-09 | サレプタ セラピューティクス， インコーポレイテッド | 筋ジストロフィを処置するためのエキソンスキッピング組成物 |
| AU2014236160A1 (en) | 2013-03-14 | 2015-10-01 | Sarepta Therapeutics, Inc. | Exon skipping compositions for treating muscular dystrophy |
| EP3662912A1 (en) | 2013-03-15 | 2020-06-10 | Sarepta Therapeutics, Inc. | Improved dosages of eteplirsen for treating duchenne muscular dystrophy |
| WO2015022663A1 (en) | 2013-08-14 | 2015-02-19 | Novartis Ag | Compounds and compositions as inhibitors of mek |
| WO2015022664A1 (en) | 2013-08-14 | 2015-02-19 | Novartis Ag | Compounds and compositions as inhibitors of mek |
| US9227969B2 (en) | 2013-08-14 | 2016-01-05 | Novartis Ag | Compounds and compositions as inhibitors of MEK |
| WO2015092634A1 (en) | 2013-12-16 | 2015-06-25 | Novartis Ag | 1,2,3,4-tetrahydroisoquinoline compounds and compositions as selective estrogen receptor antagonists and degraders |
| EP3094629B1 (en) | 2014-01-17 | 2018-08-22 | Novartis AG | 1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions thereof for inhibiting the activity of shp2 |
| JO3517B1 (ar) | 2014-01-17 | 2020-07-05 | Novartis Ag | ان-ازاسبيرو الكان حلقي كبديل مركبات اريل-ان مغايرة وتركيبات لتثبيط نشاط shp2 |
| WO2015107493A1 (en) | 2014-01-17 | 2015-07-23 | Novartis Ag | 1 -pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and and compositions thereof for inhibiting the activity of shp2 |
| US10858453B2 (en) | 2015-04-01 | 2020-12-08 | International Dioxcide, Inc. | Stabilized composition for combined odor control and enhanced dewatering |
| WO2016203405A1 (en) | 2015-06-19 | 2016-12-22 | Novartis Ag | Compounds and compositions for inhibiting the activity of shp2 |
| CN107922388B (zh) | 2015-06-19 | 2020-12-29 | 诺华股份有限公司 | 用于抑制shp2活性的化合物和组合物 |
| ES2741746T3 (es) | 2015-06-19 | 2020-02-12 | Novartis Ag | Compuestos y composiciones para inhibir la actividad de SHP2 |
| US20190054113A1 (en) | 2015-09-30 | 2019-02-21 | Sarepta Therapeutics, Inc. | Methods for treating muscular dystrophy |
| EP3449000A1 (en) | 2016-04-29 | 2019-03-06 | Sarepta Therapeutics, Inc. | Oligonucleotide analogues targeting human lmna |
| EA036446B1 (ru) | 2016-06-14 | 2020-11-11 | Новартис Аг | Соединения и композиции для подавления активности shp2 |
| MA45618A (fr) | 2016-06-30 | 2019-05-08 | Sarepta Therapeutics Inc | Sauts d'exons oligomères pour la dystrophie musculaire |
| WO2018118662A1 (en) | 2016-12-19 | 2018-06-28 | Sarepta Therapeutics, Inc. | Exon skipping oligomer conjugates for muscular dystrophy |
| DK3554553T3 (da) | 2016-12-19 | 2022-09-19 | Sarepta Therapeutics Inc | Exon-overspringnings-oligomerkonjugat til muskeldystrofi |
| HRP20240705T1 (hr) | 2016-12-19 | 2024-08-30 | Sarepta Therapeutics, Inc. | Oligomerni konjugati koji preskaču egzon za mišićnu distrofiju |
| ES2994451T3 (en) | 2017-04-20 | 2025-01-24 | Atyr Pharma Inc | Compositions for treating lung inflammation |
| EA201991450A1 (ru) | 2017-09-22 | 2019-12-30 | Сарепта Терапьютикс, Инк. | Конъюгаты олигомеров для пропуска экзона при мышечной дистрофии |
| EP3687547A1 (en) | 2017-09-28 | 2020-08-05 | Sarepta Therapeutics, Inc. | Combination therapies for treating muscular dystrophy |
| WO2019067981A1 (en) | 2017-09-28 | 2019-04-04 | Sarepta Therapeutics, Inc. | POLYTHERAPIES FOR TREATING MUSCLE DYSTROPHY |
| JP2020536057A (ja) | 2017-09-28 | 2020-12-10 | サレプタ セラピューティクス， インコーポレイテッド | 筋ジストロフィーを処置するための併用療法 |
| US10765760B2 (en) | 2018-05-29 | 2020-09-08 | Sarepta Therapeutics, Inc. | Exon skipping oligomer conjugates for muscular dystrophy |
| EP3806868A4 (en) | 2018-06-13 | 2022-06-22 | Sarepta Therapeutics, Inc. | EXON-SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY |
| CN108435148A (zh) * | 2018-06-21 | 2018-08-24 | 黄益良 | 一种环糊精改性聚丙烯酰胺污水处理剂及其制备方法 |
| TW202020153A (zh) | 2018-07-27 | 2020-06-01 | 美商薩羅塔治療公司 | 用於肌肉萎縮症之外顯子跳躍寡聚物 |
| CA3122281A1 (en) | 2018-12-13 | 2020-06-18 | Sarepta Therapeutics, Inc. | Exon skipping oligomer conjugates for muscular dystrophy |
| JP7607935B2 (ja) | 2019-01-03 | 2025-01-06 | サイクラリティ・セラピューティクス・インコーポレイテッド | シクロデキストリン二量体、それらの組成物、及びそれらの使用 |
| CN109663578B (zh) * | 2019-02-22 | 2022-02-25 | 安徽大学 | 一种对刚果红超高吸附能力的混合卤化物(MV)[BiI3Cl2]的制备方法及其产品 |
| CN109806849A (zh) * | 2019-03-25 | 2019-05-28 | 东华大学 | 一种环糊精纳米空心小球及其制备方法 |
| JP2022526763A (ja) | 2019-03-28 | 2022-05-26 | サレプタ セラピューティクス， インコーポレイテッド | カシメルセンによる筋ジストロフィーの治療方法 |
| WO2020214763A1 (en) | 2019-04-18 | 2020-10-22 | Sarepta Therapeutics, Inc. | Compositions for treating muscular dystrophy |
| WO2020257489A1 (en) | 2019-06-19 | 2020-12-24 | Sarepta Therapeutics, Inc. | Methods for treating muscular dystrophy |
| WO2021101606A1 (en) * | 2019-11-18 | 2021-05-27 | Pmidg, Llc | Compositions for sunscreen compounds and methods thereof |
| CN113019344A (zh) * | 2021-03-16 | 2021-06-25 | 大连理工大学 | 一种具有选择性吸附的球形零价铁-环糊精复合材料的制备方法及应用 |
| CN113372674B (zh) * | 2021-08-13 | 2021-10-19 | 山东三义集团股份有限公司 | 一种氯化聚乙烯用高速挤出加工改性助剂的制备方法 |
| KR20240155352A (ko) | 2022-03-17 | 2024-10-28 | 사렙타 쎄러퓨틱스 인코퍼레이티드 | 포스포로디아미데이트 모르폴리노 올리고머 접합체 |
| WO2024073570A1 (en) | 2022-09-28 | 2024-04-04 | Altos Labs, Inc. | Expression of regeneration factors in aged/senescent cells |
| WO2024145608A2 (en) | 2022-12-30 | 2024-07-04 | Cornell University | Acid cyclodextrins for the treatment of lipofuscin buildups and ocular diseases |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2801184A (en) * | 1952-01-18 | 1957-07-30 | Miyamoto Katsuhei | Colloidal suspension of amylose and alpha-amylodextrin |
| NL224464A (da) * | 1958-01-29 | |||
| US2977356A (en) * | 1958-05-27 | 1961-03-28 | Anheuser Busch | Process for preparing cross-linked starch ethers in granule form |
| US2973243A (en) * | 1958-08-26 | 1961-02-28 | Kudera Dieter | Process for producing threads, foils, tubes and the like from amylose and/or starch carbohydrates containing amylose |
| NL126243C (da) * | 1959-06-12 | |||
| US2989521A (en) * | 1959-06-30 | 1961-06-20 | Frederic R Senti | Method of cross-linking and oxidizing starch |
| US3282870A (en) * | 1963-11-29 | 1966-11-01 | Dow Chemical Co | Starch and polycarboxamide reaction products |
-
1964
- 1964-04-29 CH CH561564A patent/CH445129A/fr unknown
-
1965
- 1965-04-06 IT IT7649/65A patent/IT961352B/it active
- 1965-04-07 BE BE662174D patent/BE662174A/fr unknown
- 1965-04-20 ES ES0312034A patent/ES312034A1/es not_active Expired
- 1965-04-20 US US449619A patent/US3420788A/en not_active Expired - Lifetime
- 1965-04-20 GB GB16550/65A patent/GB1091637A/en not_active Expired
- 1965-04-27 NL NL6505361A patent/NL6505361A/xx unknown
- 1965-04-28 SE SE12182/69A patent/SE365234B/xx unknown
- 1965-04-28 SE SE5582/65A patent/SE333240B/xx unknown
- 1965-04-28 DK DK215765A patent/DK132259C/da active
- 1965-04-28 NO NO00157873A patent/NO126377B/no unknown
-
1967
- 1967-12-13 NO NO00170961A patent/NO127814B/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK132259C (da) | 1976-05-03 |
| DE1493047A1 (de) | 1969-01-02 |
| US3420788A (en) | 1969-01-07 |
| SE333240B (sv) | 1971-03-08 |
| NL6505361A (da) | 1965-11-01 |
| DE1493047B2 (de) | 1973-01-11 |
| ES312034A1 (es) | 1966-02-01 |
| CH445129A (fr) | 1967-10-15 |
| GB1091637A (en) | 1967-11-22 |
| SE365234B (da) | 1974-03-18 |
| DK132259B (da) | 1975-11-17 |
| IT961352B (it) | 1973-12-10 |
| BE662174A (da) | 1965-10-07 |
| NO126377B (da) | 1973-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO127814B (da) | ||
| NO170961B (no) | Kjemikaliebeholder og tilfoerselsanordning for fastgjoeringav denne | |
| KR920011904A (ko) | 과산화수소의 제조방법 | |
| US3160641A (en) | Purification of isosorbide | |
| JPH0141654B2 (da) | ||
| CN107027296B (zh) | 在温和操作条件下由生物质糖高产率制备呋喃的方法 | |
| Salwiński et al. | In situ one‐step method for synthesis of “click”‐functionalized monolithic stationary phase for capillary electrochromatography | |
| Quinn et al. | Kinetics of aquation of dibromo-and bromoaquobis (ethylenediamine) chromium (III) cations | |
| US3099529A (en) | Separation of nitric acid from its salts | |
| JPH0556761B2 (da) | ||
| US3939118A (en) | Process for removing contaminants from polycarbonate solutions | |
| KR910002755A (ko) | 알파-히드록시 케톤의 합성법 | |
| Yang et al. | Synthesis and evaluation of chitosan aryl azacrown ethers as adsorbents for metal ions | |
| Stewart et al. | An hydration scale for ketones in polar aprotic solvents | |
| US3753972A (en) | Fractionation of agar | |
| US3179703A (en) | Removal of phenols from their aqueous solutions with low-capacity ionexchange resins | |
| US2275151A (en) | Recovery of ethyl chloride from ethyl chloride-butane mixtures | |
| US3315002A (en) | Method of separation of lower alkyl mono-and dialcohols, acetone and methylethylketone, and ethylamine and butyl amine with novel ion exchange resin derivatives | |
| US3065222A (en) | Cation exchange starches which retain their original granular form and process for making same | |
| US5484511A (en) | Process for the removal of impurities from hydrazine hydrate | |
| KR910011877A (ko) | 아미카신의 제조방법 | |
| JP2530985B2 (ja) | クレゾ―ル異性体の分離方法 | |
| JPH0733695A (ja) | １，１−ジクロロ−１−フルオロエタンの水分除去方法 | |
| RU2046094C1 (ru) | Синтетический углеродный алмазсодержащий материал | |
| US2897238A (en) | Method for the separation of carbonyl compounds |